Your browser doesn't support javascript.
loading
Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?
Mastroeni, Pietro; Rossi, Omar.
Afiliação
  • Mastroeni P; University of Cambridge, United Kingdom pm274@cam.ac.uk.
  • Rossi O; GSK Vaccines Institute for Global Health, Siena, Italy.
Infect Immun ; 88(10)2020 09 18.
Article em En | MEDLINE | ID: mdl-32601109
ABSTRACT
Salmonella causes grave systemic infections in humans and other animals and provides a paradigm for other diseases in which the bacteria have both intracellular and extracellular lifestyles. New generations of vaccines rely on the essential contribution of the antibody responses for their protection. The quality, antigen specificity, and functions associated with antibody responses to this pathogen have been elusive for a long time. Recent approaches that combine studies in humans and genetically manipulated experimental models and that exploit awareness of the location and within-host life cycle of the pathogen are shedding light on how humoral immunity to Salmonella operates. However, this area of research remains full of controversy and discrepancies. The overall scenario indicates that antibodies are essential for resistance against systemic Salmonella infections and can express the highest protective function when operating in conjunction with cell-mediated immunity. Antigen specificity, isotype profile, Fc-gamma receptor usage, and complement activation are all intertwined factors that still arcanely influence antibody-mediated protection to Salmonella.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Salmonella / Infecções por Salmonella / Anticorpos Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Infect Immun Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Salmonella / Infecções por Salmonella / Anticorpos Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Infect Immun Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido